The share price was above Evolent’s expected IPO price of $14 to $16 per share, according to Reuters.
UPMC Health Plan and the Advisory Board each contributed $10 million to create Evolent in 2011, which has targeted hospital networks that are looking for ways to control healthcare costs, according to the Pittsburgh Business Times.
More articles on healthcare finance:
Survey shows 51% of hospital systems achieved ROI from value-based payment models
31 latest hospital credit downgrades
To Medicare, bacterial infections are billion-dollar problems
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
